Multiple peer-reviewed studies have found mesenchymal stem cell therapy (MSCT) to be a safe procedure. At MSC Stem, we have never had any patients report harmful effects from treatment or a worsening of their condition.

Common short-term side effects immediately following the cell transplant have been fatigue, headache, and nausea. The patient will be under direct medical supervision for the duration of the treatment and recovery period of 1-2 hours. We have not had any reports of short term side effects lasting for longer than 2-3 hours.

Both vaccinated and unvaccinated travelers can travel freely without restriction.

The usage of adult mesenchymal stem cells is not subject to the same ethical concerns as fetal and embryonic stem cells.

We do offer logistical support throughout the entire process. However flights, ground transportation and accommodation are not included in the base treatment cost. We have partnerships with select hotels  and can offer exclusive discounts reserved only for our patients.

We only use AATB certified suppliers of US-donated cord tissue, and do not accept outside cords, as our cGMP certified lab is specifically calibrated to accept cords from these suppliers with strict specifications. Accepting cords from outside sources puts quality control into question, and would require the production process to stop within the lab to avoid cross-contamination issues.

While this can be done, it would be at greatly heightened time and cost, for no biological benefit. Medically, there is no difference between cord sources for isolated cord tissue derived MSCs. Cord tissue stem cells are essentially “unclaimed” and immuno-priviledged, so there is no noted benefit to use cells from a family member.

With our current knowledge of stem cells, it is technically feasible to delay aging and improve both health and lifespan. Stem cells can play a crucial role in delaying the aging process. Stem cells, in combination with anti-aging genes, can create a sophisticated shield, which can prevent the effects of aging.

Stem cells, play a crucial role in delaying the aging process. Stem cells make a complex and protective shield, which stand against the eroding effects of aging. The shield of stem cells is a primary target for absorbing the shock of aging. If this shield neutralizes the shocks, it could lead to a youthful state. Studies suggest that stem cell interventions that increase rejuvenation and keep in balance the expression of anti-aging genes could delay aging and result in prolonged lifespan.

The benefits of a stem cell transplant for aging

• A feeling of vitality and rejuvenation
• Improved capacity for physical activities
• Thickening and improved quality of hair
• Increased libido
• A decrease in pain
• Increased strength, balance & overall mobility
• Enhanced immunity
• Overall improvement in the quality of life
• Immune system regulation
• Decreased inflammatory markers

No, our protocol calls for the administration of the cells at a slow rate of 1cc per minute by hand by the physician to ensure control of the infusion. This method ensures the prevention of clots and other complications. There have been no reported cases of clots or embolisms from intravenous treatment.

Yes, all tests listed on the pre-treatment package are required to be completed within the listed validity period to ensure treatment safety and efficacy.  It is also imperative for us to establish a baseline of your condition and catch anything that could potentially cause harm if unaddressed.  This is a requirement of our IRB approval, and is audited on a yearly basis. .  The requisition will include all of the required labs.

Mesenchymal stem cells (MSCs), especially those derived from umbilical cord tissue, have shown a remarkable ability to avoid entrapment in the lungs due to their optimal size (17-19 µm) and efficient navigation of the pulmonary circulation. Although MSCs may come across the pulmonary first pass effect upon intravenous administration, their extraordinary homing capabilities enable them to precisely target areas of inflammation and injury in the body, significantly enhancing their overall therapeutic efficacy. The temporary presence of MSCs in the lungs does not diminish their potential benefits; in fact, they actively exert paracrine effects by releasing trophic factors and modulating the immune response. Continuous advancements in research and optimization of MSC administration techniques unequivocally support the highly effective delivery of these invaluable cells in regenerative medicine and tissue engineering.

Yes, we have partnerships with hotels. However, accommodation is not included in the base treatment cost.

Yes, we offer interest-free financing (14 months) via our partner Advance Care Card. They aim to combine low interest rates and flexibility, to make financing simple and affordable. Apply for financing here

Yes, we have written over 80 articles specifically designed to help prospective patients learn more about mesenchymal stem cells (MSCs), stem cell therapy and other areas of regenerative medicine. We have also created a Study Database which includes a variety of third party peer reviewed research conducted on mesenchymal stem cells for a variety of different conditions.

In short, no it does not. We only offer one single protocol, the intravenous IV transplant of 300 million cord tissue-derived Mesenchymal Stem Cells (MSCs), This protocol is designed to be effective for a variety of different conditions and thus the cost of treatment will not change from what is listed on our

view costs

The stated primary goal of our protocol is the marked reduction in the levels of chronic low-grade inflammation for an extended period of time. Stem cells have a unique, intrinsic property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life.

Studies have shown that mesenchymal stem cells (MSCS) may positively impact the following conditions:

• ALS
• Alzheimer’s
• Autoimmune conditions
• COPD (or other degenerative / inflammatory lung conditions)
• COVID-19 (long-haul / acute)
• Chronic Inflammation
• Crohn’s Disease
• Diabetes (Type 1)
• Heart Failure / Heart Disease
• Kidney Disease
• Liver Disease
• Lupus
• Lyme Disease
• Multiple Sclerosis
• Neurological Conditions (degenerative)
• Neuropathy
• Parkinson’s
• Reflex Sympathetic Dystrophy (RSD) or (CRPS)
• Rheumatoid Arthritis
• Spinal Cord Injuries
• Stroke (ischemic & hemiplegic)
• Traumatic Brain Injury (TBI)

In order to determine treatment candidacy we request that all patients complete an application online. This screening application will give our medical team the preliminary information needed in order to determine if the applicant may be a candidate for our IRB-approved protocol. Once completed you will receive a follow-up email within 72 hours with further onboarding instructions. We have a three step onboarding process every patient must follow prior to final treatment clearance:

Step 1: Complete Screening Application

Step 2: Complete Patient Intake Forms

Step 3: Complete Treatment Prerequisites (Labs, Exams, Imaging)

Treatment results are quantified by measuring changes in unique inflammatory markers in conjunction with subjective data provided in PAR-Q vitality questionnaires. Our patient management team will follow-up with patients every 3 months for 24 months post-treatment in order to collect post-treatment efficacy data.

Currently the clinical use of expanded stem cells is not authorized in the United States. Despite the clinical evidence, the United States still has very strict regulations and laws against stem cell treatments. While you may find many clinics in the US offering “stem cell therapies”, these therapies are highly restricted in scope and number of cells used and quality of those stem cells.

It is because of these laws in the US that many have traveled abroad to receive the latest therapies, including many high-profile athletes and celebrities. It has created a booming medical tourism industry in the last decade. DVC Stem seeks to provide patients with safe and effective treatments, in a safe, luxurious, and beautiful setting.

Patient response to treatment is dependent on a large variety of biological factors, however is also subject to the behavior and lifestyle of the patient. Patients who adhere to an active lifestyle, anti-inflammatory diet, and restrict the consumption of alcohol, tobacco, and caffeine can seen sustained results for 2+ years, depending on condition. On average, patients have reported little signs of regression up to 24 months following treatment and patients rarely return to their pre-treatment state.

Please note: every patient is different and responds to treatment in their own way. There is currently no way to accurately predict the results of any stem cell treatment. We highly encourage prospective patients to do their research before pursuing treatment. It is still a new, but promising field for treating many conditions which could otherwise not be treated.

Treatment may produce measurable results within 3-6 months following treatment. This is indicated by a marked reduction in levels of inflammation and changes in general vitality as measure by our follow-up questionnaire. However, it is common for patients to report improvements in their quality of life and a lessening of their symptoms within the first few weeks following treatment. However, every patient is unique and may respond to treatment differently.

The length of the onboarding process is highly dependent upon the patients ability to provide the necessary pre-treatment documentation / lab work in a timely manner – on average it will take patients roughly 2-3 weeks to obtain the required material. Once our medical team received the entirely of the requirements the patients file will be reviewed within 72 hours. Once reviewed the patient may then proceed with booking a treatment date – we typically have a 1-2 month scheduling lead time.

The cost of treatment starts at €0,0 . You will receive a quote after you have completed your screening application. Travel and accommodation are not included in the base treatment cost. You can learn more about our pricing 

view costs

Payment Policy

To confirm your treatment date we require a 50% deposit, with the remainder of the balance being due no later than two weeks prior to your scheduled treatment date.

Payment Methods

We accept global payments via international bank / wire transfer, Visa & Mastercard as well as most debit cards. (please note that a 4% convenience fee will be added to credit/debit card payments)

The purpose of the Screening Application is to eliminate applicants that may not be a candidate for treatment prior to starting the onboarding process. Once the onboarding process has begun, a variety of tests will be requested to ensure the patients is cleared of any active cancer or infections which may impact treatment eligibility.

Yes, MSCStem a is fully licensed healthcare facility.

No, unfortunately treatment costs are not commonly covered by insurance.

Mesenchymal stem cell therapy may be able to help a variety of different conditions. The stated primary goal of our protocol is the marked reduction in the levels of chronic low-grade inflammation for an extended period of time. Stem cells have a unique, intrinsic property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life.

Studies have shown that mesenchymal stem cells (MSCS) may positively impact the following conditions:

• ALS
• Alzheimer’s
• Autoimmune conditions
• COPD (or other degenerative / inflammatory lung conditions)
• COVID-19 (long-haul / acute)
• Chronic Inflammation
• Crohn’s Disease
• Diabetes (Type 1)
• Heart Failure / Heart Disease
• Kidney Disease
• Liver Disease
• Lupus
• Lyme Disease
• Multiple Sclerosis
• Neurological Conditions (degenerative)
• Neuropathy
• Parkinson’s
• Reflex Sympathetic Dystrophy (RSD) or (CRPS)
• Rheumatoid Arthritis
• Spinal Cord Injuries
• Stroke (ischemic & hemiplegic)
• Traumatic Brain Injury (TBI)

If you do not see your condition listed above please complete a contact forms  so that our medical team may manually review your case and also search for your diagnosis in our Study database

In order to ensure patient safety and treatment efficacy we require all patients to complete a panel of labs, medical exams and imaging prior to final treatment clearance. The information provided will allow our medical team to establish a baseline of your pre-treatment status or catch anything that could potentially cause harm if unaddressed.

The specific requirements will be provided in detail via email after the initial screening application has been completed. Additionally we have a patient management team that is available to help answer any questions related to the onboarding process.

The stated primary goal of our protocol is the marked reduction in the levels of chronic low-grade inflammation for an extended period of time.

‍Stem cells have a unique, intrinsic property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life.

Depending on the primary ailment or initial condition of the patient, the effects of stem cell therapy can lead to a reduction in harmful symptoms, stabalization of condition and a significant quality of life improvement an extended period of time.

All deposits are fully refundable up to two weeks prior to the scheduled treatment date. If you are unable to make your appointment or need to reschedule, our patient management team can help you organize another date for no extra charge.

We are currently still collecting long-term data and do not have any published results to share specifically related to our IRB-approved clinical trials.(Trial HPC/CTR/003). However, preliminary data that has been collected over the past 4 years has been exciting.

Patient reported results have since shown that ~85% of our total patient population have noted a sustained improvement in their condition within 3 months of treatment. This data is measured via a follow-up vitality questionnaire that is compared to baseline results collected within 3 months prior to treatment in conjunction with unique inflammatory marker testing.

More specifically, the current average improvements for our  patients 3 months after treatment are as follows:

• 75% increase in Stamina
• 53.75% increase in Libido
• 51.40% increase in Energy Levels
• 43.97% increase in Balance
• 28% increase in Coordination
• 23.19% increase in Strength
• 21% increase in Vision

Average improvements concerning cognitive function 12 months after treatment are as follows:

• 19.84% improvement in Memory
• 44% improvement in Ability to Concentrate
• 31.94% improvement in Decision Making
• 12.5% increase in Quality of Sleep

Our protocol utilizes culture-expanded umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs).

Our cells are ethically sourced from AATB certified, US-donated, full term human umbilical cords and processed in our award-winning partner medical laboratory located in the USA, which is fully FDA registered, cGMP compliant, ISO 9001, and ISO 13485 certified. The cells are tested to ISCT standards for viability to ensure they meet minimum QA requirements multiple times before treatment.

To ensure cell safety, we conduct advanced therapy testing for sterility, endotoxins, mycoplasma, HIV-1/HIV-2, Hepatitis B, Hepatitis C and Syphillis. We also conduct confirmation of identity URMC Flow Cytometry testing to ensure post-thaw viability, and MSC phenotype expression (CD73+, CD90+, CD105, etc.)

‍

MSCStem is located in the Netherlands.

In accordance with FDA regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. This group review serves an important role in the protection of the rights and welfare of human research subjects.

The purpose of IRB review is to assure, both in advance and by periodic review, that appropriate steps are taken to protect the rights and welfare of humans participating as subjects in the research. To accomplish this purpose, IRBs use a group process to review research protocols and related materials (e.g., informed consent documents and investigator brochures) to ensure protection of the rights and welfare of human subjects of research.

The primary goal of our protocol is to promote long-term condition stabalization and we do not require follow-up treatments. Some do choose to return for follow-up treatment voluntarily, most commonly to achieve further improvements. We generally do not recommend more than one treatment per year for most degenerative conditions.